Takeda Pharmaceutical Co Ltd (TAK)
13.08
-0.09
(-0.68%)
USD |
NYSE |
Apr 30, 16:00
13.08
0.00 (0.00%)
Pre-Market: 20:00
Takeda Pharmaceutical Market Cap: 41.04B for April 30, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 30, 2024 | 41.04B |
| April 29, 2024 | 41.33B |
| April 26, 2024 | 40.89B |
| April 25, 2024 | 41.01B |
| April 24, 2024 | 41.51B |
| April 23, 2024 | 41.98B |
| April 22, 2024 | 41.92B |
| April 19, 2024 | 41.54B |
| April 18, 2024 | 41.29B |
| April 17, 2024 | 41.26B |
| April 16, 2024 | 41.51B |
| April 15, 2024 | 41.36B |
| April 12, 2024 | 41.95B |
| April 11, 2024 | 42.61B |
| April 10, 2024 | 42.58B |
| April 09, 2024 | 42.83B |
| April 08, 2024 | 42.89B |
| April 05, 2024 | 42.74B |
| April 04, 2024 | 42.30B |
| April 03, 2024 | 42.45B |
| April 02, 2024 | 42.52B |
| April 01, 2024 | 42.89B |
| March 28, 2024 | 43.58B |
| March 27, 2024 | 44.53B |
| March 26, 2024 | 45.15B |
| Date | Value |
|---|---|
| March 25, 2024 | 44.40B |
| March 22, 2024 | 45.22B |
| March 21, 2024 | 45.06B |
| March 20, 2024 | 45.66B |
| March 19, 2024 | 45.22B |
| March 18, 2024 | 45.69B |
| March 15, 2024 | 45.40B |
| March 14, 2024 | 45.00B |
| March 13, 2024 | 45.25B |
| March 12, 2024 | 45.09B |
| March 11, 2024 | 45.72B |
| March 08, 2024 | 46.35B |
| March 07, 2024 | 46.63B |
| March 06, 2024 | 46.09B |
| March 05, 2024 | 45.18B |
| March 04, 2024 | 45.44B |
| March 01, 2024 | 45.69B |
| February 29, 2024 | 45.78B |
| February 28, 2024 | 45.97B |
| February 27, 2024 | 46.57B |
| February 26, 2024 | 46.47B |
| February 23, 2024 | 45.88B |
| February 22, 2024 | 45.94B |
| February 21, 2024 | 46.25B |
| February 20, 2024 | 46.50B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
38.61B
Minimum
Oct 19 2022
65.67B
Maximum
Nov 19 2019
50.57B
Average
50.74B
Median
Sep 15 2023
Market Cap Benchmarks
| Hoya Corp | 40.69B |
| Astellas Pharma Inc | 17.12B |
| Nxera Pharma Co Ltd | 832.20M |
| PeptiDream Inc | 1.699B |
| Stemcell Holdings Inc | 1.643M |
Market Cap Related Metrics
| PE Ratio | 32.58 |
| PS Ratio | 1.388 |
| Price to Book Value | 0.8585 |
| Price | 13.08 |
| Earnings Yield | 3.07% |
| Operating PE Ratio | 16.62 |
| Normalized PE Ratio | 32.58 |